They ran through a menu of takes on biotech stock performance, M&A, Food and Drug Administration turmoil, election intrigue, ...
The order aims to shore up production of the herbicide glyphosate (better known as the active ingredient in the weed killer ...
FDA Commissioner Marty Makary defended the agency’s recent rejections of rare disease drugs and one of his deputies, Vinay ...
Today, a story about the regulatory challenges behind the Neuralink hype.
Pharmalittle: We’re reading about Trump’s drug-price claims, a Novo deal for obesity drugs, and more
In his State of the Union address, President Trump claimed he had brought U.S. prescription drug costs from the highest in the world to the lowest ...
Thirty years after scientists demonstrated how brain implants can help rhesus monkeys move robotic limbs using only their ...
The Trump administration issued a nationwide moratorium on new suppliers for certain medical equipment, citing fraud.
Her son Ben, she learned, had mucopolysaccharidosis (MPS) type 2, or Hunter Syndrome, one of a group of rare diseases that is ...
When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...
Xenon Pharmaceuticals is developing a drug for the most common type of seizure experienced by people with epilepsy. Here's ...
Vice President JD Vance announced Wednesday that the Trump administration would “temporarily halt” some Medicaid funding to ...
Sarepta's CEO will retire after a tumultuous decade in which Sarepta became a $15 billion company — and then that value ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results